Review



cfgf23 enzyme linked immunosorbent assay elisa  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    R&D Systems cfgf23 enzyme linked immunosorbent assay elisa
    Phosphatropic hormones after 5 days of low- or high-phosphate (P i ) diet. Levels of A serum parathyroid hormone (PTH), B plasma intact fibroblast growth factor 23 <t>(iFGF23),</t> C plasma C-terminal FGF23 <t>(cFGF23),</t> D the ratio of iFGF23 (ng/l)/cFGF23 (ng/l) as well as serum E calcidiol, and F calcitriol, and G plasma soluble Klotho, and H Fetuin-A on the final day of both the 5-day low and high P i diet. One reference unit (RU)/ml corresponds to 2 ng/l cFGF23. Blue dots represent differences (Δ) between high P i diet and low P i diet expressed as mean difference ± 95% confidence interval and blue dashed line represents the zero line of the right y-axis. Data was analyzed by the paired t -test ( A – E ) or Wilcoxon test ( F–H ), n = 10, * p < 0.05
    Cfgf23 Enzyme Linked Immunosorbent Assay Elisa, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 42 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cfgf23+enzyme+linked+immunosorbent+assay+elisa/Human+Fetuin+A+Quantikine+ELISA+Kit/pmc11825603-106-228-243
    Average 93 stars, based on 42 article reviews
    cfgf23 enzyme linked immunosorbent assay elisa - by Bioz Stars, 2026-10
    93/100 stars

    Images

    1) Product Images from "Controlled dietary phosphate loading in healthy young men elevates plasma phosphate and FGF23 levels"

    Article Title: Controlled dietary phosphate loading in healthy young men elevates plasma phosphate and FGF23 levels

    Journal: Pflugers Archiv

    doi: 10.1007/s00424-024-03046-4

    Phosphatropic hormones after 5 days of low- or high-phosphate (P i ) diet. Levels of A serum parathyroid hormone (PTH), B plasma intact fibroblast growth factor 23 (iFGF23), C plasma C-terminal FGF23 (cFGF23), D the ratio of iFGF23 (ng/l)/cFGF23 (ng/l) as well as serum E calcidiol, and F calcitriol, and G plasma soluble Klotho, and H Fetuin-A on the final day of both the 5-day low and high P i diet. One reference unit (RU)/ml corresponds to 2 ng/l cFGF23. Blue dots represent differences (Δ) between high P i diet and low P i diet expressed as mean difference ± 95% confidence interval and blue dashed line represents the zero line of the right y-axis. Data was analyzed by the paired t -test ( A – E ) or Wilcoxon test ( F–H ), n = 10, * p < 0.05
    Figure Legend Snippet: Phosphatropic hormones after 5 days of low- or high-phosphate (P i ) diet. Levels of A serum parathyroid hormone (PTH), B plasma intact fibroblast growth factor 23 (iFGF23), C plasma C-terminal FGF23 (cFGF23), D the ratio of iFGF23 (ng/l)/cFGF23 (ng/l) as well as serum E calcidiol, and F calcitriol, and G plasma soluble Klotho, and H Fetuin-A on the final day of both the 5-day low and high P i diet. One reference unit (RU)/ml corresponds to 2 ng/l cFGF23. Blue dots represent differences (Δ) between high P i diet and low P i diet expressed as mean difference ± 95% confidence interval and blue dashed line represents the zero line of the right y-axis. Data was analyzed by the paired t -test ( A – E ) or Wilcoxon test ( F–H ), n = 10, * p < 0.05

    Techniques Used: Clinical Proteomics

    Plasma/serum and urine hormones after 5 days of low- or high-phosphate (P i ) diet. Data are presented either as mean ± SD (paired t -test) or median and interquartile range (Wilcoxon test)
    Figure Legend Snippet: Plasma/serum and urine hormones after 5 days of low- or high-phosphate (P i ) diet. Data are presented either as mean ± SD (paired t -test) or median and interquartile range (Wilcoxon test)

    Techniques Used: Clinical Proteomics

    Associations between phosphatropic hormones and tubular maximal phosphate reabsorption. Non-linear regression analysis of plasma intact fibroblast growth factor 23 (iFGF23) ( A ), C-terminal FGF23 (cFGF23) ( B ), and serum parathyroid hormone (PTH) ( C ) with tubular maximum phosphate (P i ) reabsorption (TmP/GFR) and of serum calcitriol ( D ), plasma cFGF23 ( E ), and serum PTH ( F ) with plasma iFGF23. A straight black line was fitted and ROUT method for outlier removal was applied. Black and red dots represent participants on low or high P i diet, respectively. Blue dots represent identified outliers. The dashed line represents 95% confidence interval. The slope was analyzed by the extra sum-of-squares F test. Significance level p < 0.05
    Figure Legend Snippet: Associations between phosphatropic hormones and tubular maximal phosphate reabsorption. Non-linear regression analysis of plasma intact fibroblast growth factor 23 (iFGF23) ( A ), C-terminal FGF23 (cFGF23) ( B ), and serum parathyroid hormone (PTH) ( C ) with tubular maximum phosphate (P i ) reabsorption (TmP/GFR) and of serum calcitriol ( D ), plasma cFGF23 ( E ), and serum PTH ( F ) with plasma iFGF23. A straight black line was fitted and ROUT method for outlier removal was applied. Black and red dots represent participants on low or high P i diet, respectively. Blue dots represent identified outliers. The dashed line represents 95% confidence interval. The slope was analyzed by the extra sum-of-squares F test. Significance level p < 0.05

    Techniques Used: Clinical Proteomics

    Related Articles

    Clinical Proteomics:

    Article Title: Controlled dietary phosphate loading in healthy young men elevates plasma phosphate and FGF23 levels
    Article Snippet: .. Tubular maximum P i reabsorption (TmP/GFR) was calculated by using the fractional tubular reabsorption (TRP) of P i with the following equations using spot urine [ ]: \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\begin{array}{l}TRP=1-\left[\left(\frac{{U}_{Pi}}{{P}_{Pi}}\right)*\left(\frac{{P}_{Cr}}{{U}_{Cr}}\right)\right]\\ TRP \le 0.86 \to TmP/GFR=TRP*{P}_{Pi}\\ TRP>0.86 \to TmP/GFR=\left(0.3*\frac{TRP}{1-\left(0.8*TRP\right)}\right)*{P}_{Pi}\end{array}$$\end{document} T R P = 1 - U Pi P Pi ∗ P Cr U Cr T R P ≤ 0.86 → T m P / G F R = T R P ∗ P Pi T R P > 0.86 → T m P / G F R = 0.3 ∗ TRP 1 - 0.8 ∗ T R P ∗ P Pi Daily fractional excretion of P i (FEP i ) was calculated by the following equation using the absolute 24-h urine P i and creatinine: \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$FE{P}_{i}=\frac{{(U}_{Pi}*{P}_{Cr})}{{(P}_{Pi}*{U}_{Cr})}*100$$\end{document} F E P i = ( U Pi ∗ P Cr ) ( P Pi ∗ U Cr ) ∗ 100 Daily renal filtered P i load was calculated with the following equation: \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$Renal\;P_iload/day=\left(\frac{U_{Cr}\ast U_{volume}}{P_{Cr}\ast1440}\right)\ast P_{Pi}$$\end{document} R e n a l P i l o a d / d a y = U Cr * U volume P Cr * 1440 * P Pi Plasma iFGF23, cFGF23, Fetuin-A, and urinary metanephrine were measured with the human iFGF23 and cFGF23 enzyme-linked immunosorbent assay (ELISA) (iFGF23 and cFGF23, Quidel, 60–6600 and 60–6100, respectively), Fetuin-A ELISA (R&D Systems, DFTA00, Lot P413286), and the Metanephrine Urine ELISA (Demeditec Diagnostics GmbH, DEE8400) according to manufacturers’ protocols. ..

    Article Title: Controlled dietary phosphate loading in healthy young men elevates plasma phosphate and FGF23 levels.
    Article Snippet: .. Daily fractional excretion of Pi (FEPi) was calculated by the following equation using the absolute 24-h urine Pi and creatinine: Daily renal filtered Pi load was calculated with the following equation: Plasma iFGF23, cFGF23, Fetuin-A, and urinary metanephrine were measured with the human iFGF23 and cFGF23 enzyme-linked immunosorbent assay (ELISA) (iFGF23 and cFGF23, Quidel, 60–6600 and 60–6100, respectively), Fetuin-A ELISA (R&D Systems, DFTA00, Lot P413286), and the Metanephrine Urine ELISA (Demeditec Diagnostics GmbH, DEE8400) according to manufacturers’ protocols. ..

    Enzyme-linked Immunosorbent Assay:

    Article Title: Controlled dietary phosphate loading in healthy young men elevates plasma phosphate and FGF23 levels
    Article Snippet: .. Tubular maximum P i reabsorption (TmP/GFR) was calculated by using the fractional tubular reabsorption (TRP) of P i with the following equations using spot urine [ ]: \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\begin{array}{l}TRP=1-\left[\left(\frac{{U}_{Pi}}{{P}_{Pi}}\right)*\left(\frac{{P}_{Cr}}{{U}_{Cr}}\right)\right]\\ TRP \le 0.86 \to TmP/GFR=TRP*{P}_{Pi}\\ TRP>0.86 \to TmP/GFR=\left(0.3*\frac{TRP}{1-\left(0.8*TRP\right)}\right)*{P}_{Pi}\end{array}$$\end{document} T R P = 1 - U Pi P Pi ∗ P Cr U Cr T R P ≤ 0.86 → T m P / G F R = T R P ∗ P Pi T R P > 0.86 → T m P / G F R = 0.3 ∗ TRP 1 - 0.8 ∗ T R P ∗ P Pi Daily fractional excretion of P i (FEP i ) was calculated by the following equation using the absolute 24-h urine P i and creatinine: \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$FE{P}_{i}=\frac{{(U}_{Pi}*{P}_{Cr})}{{(P}_{Pi}*{U}_{Cr})}*100$$\end{document} F E P i = ( U Pi ∗ P Cr ) ( P Pi ∗ U Cr ) ∗ 100 Daily renal filtered P i load was calculated with the following equation: \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$Renal\;P_iload/day=\left(\frac{U_{Cr}\ast U_{volume}}{P_{Cr}\ast1440}\right)\ast P_{Pi}$$\end{document} R e n a l P i l o a d / d a y = U Cr * U volume P Cr * 1440 * P Pi Plasma iFGF23, cFGF23, Fetuin-A, and urinary metanephrine were measured with the human iFGF23 and cFGF23 enzyme-linked immunosorbent assay (ELISA) (iFGF23 and cFGF23, Quidel, 60–6600 and 60–6100, respectively), Fetuin-A ELISA (R&D Systems, DFTA00, Lot P413286), and the Metanephrine Urine ELISA (Demeditec Diagnostics GmbH, DEE8400) according to manufacturers’ protocols. ..

    Article Title: Controlled dietary phosphate loading in healthy young men elevates plasma phosphate and FGF23 levels.
    Article Snippet: .. Daily fractional excretion of Pi (FEPi) was calculated by the following equation using the absolute 24-h urine Pi and creatinine: Daily renal filtered Pi load was calculated with the following equation: Plasma iFGF23, cFGF23, Fetuin-A, and urinary metanephrine were measured with the human iFGF23 and cFGF23 enzyme-linked immunosorbent assay (ELISA) (iFGF23 and cFGF23, Quidel, 60–6600 and 60–6100, respectively), Fetuin-A ELISA (R&D Systems, DFTA00, Lot P413286), and the Metanephrine Urine ELISA (Demeditec Diagnostics GmbH, DEE8400) according to manufacturers’ protocols. ..



    Similar Products

    93
    R&D Systems cfgf23 enzyme linked immunosorbent assay elisa
    Phosphatropic hormones after 5 days of low- or high-phosphate (P i ) diet. Levels of A serum parathyroid hormone (PTH), B plasma intact fibroblast growth factor 23 <t>(iFGF23),</t> C plasma C-terminal FGF23 <t>(cFGF23),</t> D the ratio of iFGF23 (ng/l)/cFGF23 (ng/l) as well as serum E calcidiol, and F calcitriol, and G plasma soluble Klotho, and H Fetuin-A on the final day of both the 5-day low and high P i diet. One reference unit (RU)/ml corresponds to 2 ng/l cFGF23. Blue dots represent differences (Δ) between high P i diet and low P i diet expressed as mean difference ± 95% confidence interval and blue dashed line represents the zero line of the right y-axis. Data was analyzed by the paired t -test ( A – E ) or Wilcoxon test ( F–H ), n = 10, * p < 0.05
    Cfgf23 Enzyme Linked Immunosorbent Assay Elisa, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cfgf23+enzyme+linked+immunosorbent+assay+elisa/Human+Fetuin+A+Quantikine+ELISA+Kit/pmc11825603-106-228-243
    Average 93 stars, based on 1 article reviews
    cfgf23 enzyme linked immunosorbent assay elisa - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    95
    Quidel cfgf23 enzyme linked immunosorbent assay elisa
    Phosphatropic hormones after 5 days of low- or high-phosphate (P i ) diet. Levels of A serum parathyroid hormone (PTH), B plasma intact fibroblast growth factor 23 <t>(iFGF23),</t> C plasma C-terminal FGF23 <t>(cFGF23),</t> D the ratio of iFGF23 (ng/l)/cFGF23 (ng/l) as well as serum E calcidiol, and F calcitriol, and G plasma soluble Klotho, and H Fetuin-A on the final day of both the 5-day low and high P i diet. One reference unit (RU)/ml corresponds to 2 ng/l cFGF23. Blue dots represent differences (Δ) between high P i diet and low P i diet expressed as mean difference ± 95% confidence interval and blue dashed line represents the zero line of the right y-axis. Data was analyzed by the paired t -test ( A – E ) or Wilcoxon test ( F–H ), n = 10, * p < 0.05
    Cfgf23 Enzyme Linked Immunosorbent Assay Elisa, supplied by Quidel, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cfgf23+enzyme+linked+immunosorbent+assay+elisa/pmc11825603-106-228-236
    Average 95 stars, based on 1 article reviews
    cfgf23 enzyme linked immunosorbent assay elisa - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    90
    Immutopics Inc human c-terminal-fgf23 (cfgf23) enzyme-linked immunosorbent assay (elisa) kit
    Phosphatropic hormones after 5 days of low- or high-phosphate (P i ) diet. Levels of A serum parathyroid hormone (PTH), B plasma intact fibroblast growth factor 23 <t>(iFGF23),</t> C plasma C-terminal FGF23 <t>(cFGF23),</t> D the ratio of iFGF23 (ng/l)/cFGF23 (ng/l) as well as serum E calcidiol, and F calcitriol, and G plasma soluble Klotho, and H Fetuin-A on the final day of both the 5-day low and high P i diet. One reference unit (RU)/ml corresponds to 2 ng/l cFGF23. Blue dots represent differences (Δ) between high P i diet and low P i diet expressed as mean difference ± 95% confidence interval and blue dashed line represents the zero line of the right y-axis. Data was analyzed by the paired t -test ( A – E ) or Wilcoxon test ( F–H ), n = 10, * p < 0.05
    Human C Terminal Fgf23 (Cfgf23) Enzyme Linked Immunosorbent Assay (Elisa) Kit, supplied by Immutopics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cfgf23+enzyme+linked+immunosorbent+assay+elisa/fgf+23/pmc06075072-82-10-18
    Average 90 stars, based on 1 article reviews
    human c-terminal-fgf23 (cfgf23) enzyme-linked immunosorbent assay (elisa) kit - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Immutopics Inc rodent-specific cfgf23 and ifgf23 enzyme-linked immunosorbent assay (elisa) kits
    Acute effects of a single PTH injection in WT mice. Baseline <t>cFGF23</t> levels in different experiments ranged between 218 ± 19 and 345 ± 34 pg/mL, and peak cFGF23 levels ranged between 578 ± 114 and 1244 ± 110 pg/mL; therefore, changes in cFGF23 (and iFGF23) levels are reported as percentage of change from baseline. (a) Plasma phosphate levels 2, 6, and 24 hours after PTH or vehicle injection. (b) Plasma cFGF23 levels, expressed as percentage over preinjection baseline, at 2, 4, 6, and 24 hours after PTH injection. (c) Plasma iFGF23 levels, expressed as percentage over preinjection baseline, at 2, 4, 6, and 24 hours after PTH injection. n = 5 or more mice per group. (d) Ratio of cleaved/total FGF23 was calculated as follows: (value measured by cFGF23 ELISA − value measured by iFGF23 ELISA)/value measured by cFGF23 ELISA. n = 7–8 per group. *P < 0.05.
    Rodent Specific Cfgf23 And Ifgf23 Enzyme Linked Immunosorbent Assay (Elisa) Kits, supplied by Immutopics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cfgf23+enzyme+linked+immunosorbent+assay+elisa/ifgf23/pmc05460828-58-6-14
    Average 90 stars, based on 1 article reviews
    rodent-specific cfgf23 and ifgf23 enzyme-linked immunosorbent assay (elisa) kits - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    Image Search Results


    Phosphatropic hormones after 5 days of low- or high-phosphate (P i ) diet. Levels of A serum parathyroid hormone (PTH), B plasma intact fibroblast growth factor 23 (iFGF23), C plasma C-terminal FGF23 (cFGF23), D the ratio of iFGF23 (ng/l)/cFGF23 (ng/l) as well as serum E calcidiol, and F calcitriol, and G plasma soluble Klotho, and H Fetuin-A on the final day of both the 5-day low and high P i diet. One reference unit (RU)/ml corresponds to 2 ng/l cFGF23. Blue dots represent differences (Δ) between high P i diet and low P i diet expressed as mean difference ± 95% confidence interval and blue dashed line represents the zero line of the right y-axis. Data was analyzed by the paired t -test ( A – E ) or Wilcoxon test ( F–H ), n = 10, * p < 0.05

    Journal: Pflugers Archiv

    Article Title: Controlled dietary phosphate loading in healthy young men elevates plasma phosphate and FGF23 levels

    doi: 10.1007/s00424-024-03046-4

    Figure Lengend Snippet: Phosphatropic hormones after 5 days of low- or high-phosphate (P i ) diet. Levels of A serum parathyroid hormone (PTH), B plasma intact fibroblast growth factor 23 (iFGF23), C plasma C-terminal FGF23 (cFGF23), D the ratio of iFGF23 (ng/l)/cFGF23 (ng/l) as well as serum E calcidiol, and F calcitriol, and G plasma soluble Klotho, and H Fetuin-A on the final day of both the 5-day low and high P i diet. One reference unit (RU)/ml corresponds to 2 ng/l cFGF23. Blue dots represent differences (Δ) between high P i diet and low P i diet expressed as mean difference ± 95% confidence interval and blue dashed line represents the zero line of the right y-axis. Data was analyzed by the paired t -test ( A – E ) or Wilcoxon test ( F–H ), n = 10, * p < 0.05

    Article Snippet: Tubular maximum P i reabsorption (TmP/GFR) was calculated by using the fractional tubular reabsorption (TRP) of P i with the following equations using spot urine [ ]: \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\begin{array}{l}TRP=1-\left[\left(\frac{{U}_{Pi}}{{P}_{Pi}}\right)*\left(\frac{{P}_{Cr}}{{U}_{Cr}}\right)\right]\\ TRP \le 0.86 \to TmP/GFR=TRP*{P}_{Pi}\\ TRP>0.86 \to TmP/GFR=\left(0.3*\frac{TRP}{1-\left(0.8*TRP\right)}\right)*{P}_{Pi}\end{array}$$\end{document} T R P = 1 - U Pi P Pi ∗ P Cr U Cr T R P ≤ 0.86 → T m P / G F R = T R P ∗ P Pi T R P > 0.86 → T m P / G F R = 0.3 ∗ TRP 1 - 0.8 ∗ T R P ∗ P Pi Daily fractional excretion of P i (FEP i ) was calculated by the following equation using the absolute 24-h urine P i and creatinine: \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$FE{P}_{i}=\frac{{(U}_{Pi}*{P}_{Cr})}{{(P}_{Pi}*{U}_{Cr})}*100$$\end{document} F E P i = ( U Pi ∗ P Cr ) ( P Pi ∗ U Cr ) ∗ 100 Daily renal filtered P i load was calculated with the following equation: \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$Renal\;P_iload/day=\left(\frac{U_{Cr}\ast U_{volume}}{P_{Cr}\ast1440}\right)\ast P_{Pi}$$\end{document} R e n a l P i l o a d / d a y = U Cr * U volume P Cr * 1440 * P Pi Plasma iFGF23, cFGF23, Fetuin-A, and urinary metanephrine were measured with the human iFGF23 and cFGF23 enzyme-linked immunosorbent assay (ELISA) (iFGF23 and cFGF23, Quidel, 60–6600 and 60–6100, respectively), Fetuin-A ELISA (R&D Systems, DFTA00, Lot P413286), and the Metanephrine Urine ELISA (Demeditec Diagnostics GmbH, DEE8400) according to manufacturers’ protocols.

    Techniques: Clinical Proteomics

    Plasma/serum and urine hormones after 5 days of low- or high-phosphate (P i ) diet. Data are presented either as mean ± SD (paired t -test) or median and interquartile range (Wilcoxon test)

    Journal: Pflugers Archiv

    Article Title: Controlled dietary phosphate loading in healthy young men elevates plasma phosphate and FGF23 levels

    doi: 10.1007/s00424-024-03046-4

    Figure Lengend Snippet: Plasma/serum and urine hormones after 5 days of low- or high-phosphate (P i ) diet. Data are presented either as mean ± SD (paired t -test) or median and interquartile range (Wilcoxon test)

    Article Snippet: Tubular maximum P i reabsorption (TmP/GFR) was calculated by using the fractional tubular reabsorption (TRP) of P i with the following equations using spot urine [ ]: \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\begin{array}{l}TRP=1-\left[\left(\frac{{U}_{Pi}}{{P}_{Pi}}\right)*\left(\frac{{P}_{Cr}}{{U}_{Cr}}\right)\right]\\ TRP \le 0.86 \to TmP/GFR=TRP*{P}_{Pi}\\ TRP>0.86 \to TmP/GFR=\left(0.3*\frac{TRP}{1-\left(0.8*TRP\right)}\right)*{P}_{Pi}\end{array}$$\end{document} T R P = 1 - U Pi P Pi ∗ P Cr U Cr T R P ≤ 0.86 → T m P / G F R = T R P ∗ P Pi T R P > 0.86 → T m P / G F R = 0.3 ∗ TRP 1 - 0.8 ∗ T R P ∗ P Pi Daily fractional excretion of P i (FEP i ) was calculated by the following equation using the absolute 24-h urine P i and creatinine: \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$FE{P}_{i}=\frac{{(U}_{Pi}*{P}_{Cr})}{{(P}_{Pi}*{U}_{Cr})}*100$$\end{document} F E P i = ( U Pi ∗ P Cr ) ( P Pi ∗ U Cr ) ∗ 100 Daily renal filtered P i load was calculated with the following equation: \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$Renal\;P_iload/day=\left(\frac{U_{Cr}\ast U_{volume}}{P_{Cr}\ast1440}\right)\ast P_{Pi}$$\end{document} R e n a l P i l o a d / d a y = U Cr * U volume P Cr * 1440 * P Pi Plasma iFGF23, cFGF23, Fetuin-A, and urinary metanephrine were measured with the human iFGF23 and cFGF23 enzyme-linked immunosorbent assay (ELISA) (iFGF23 and cFGF23, Quidel, 60–6600 and 60–6100, respectively), Fetuin-A ELISA (R&D Systems, DFTA00, Lot P413286), and the Metanephrine Urine ELISA (Demeditec Diagnostics GmbH, DEE8400) according to manufacturers’ protocols.

    Techniques: Clinical Proteomics

    Associations between phosphatropic hormones and tubular maximal phosphate reabsorption. Non-linear regression analysis of plasma intact fibroblast growth factor 23 (iFGF23) ( A ), C-terminal FGF23 (cFGF23) ( B ), and serum parathyroid hormone (PTH) ( C ) with tubular maximum phosphate (P i ) reabsorption (TmP/GFR) and of serum calcitriol ( D ), plasma cFGF23 ( E ), and serum PTH ( F ) with plasma iFGF23. A straight black line was fitted and ROUT method for outlier removal was applied. Black and red dots represent participants on low or high P i diet, respectively. Blue dots represent identified outliers. The dashed line represents 95% confidence interval. The slope was analyzed by the extra sum-of-squares F test. Significance level p < 0.05

    Journal: Pflugers Archiv

    Article Title: Controlled dietary phosphate loading in healthy young men elevates plasma phosphate and FGF23 levels

    doi: 10.1007/s00424-024-03046-4

    Figure Lengend Snippet: Associations between phosphatropic hormones and tubular maximal phosphate reabsorption. Non-linear regression analysis of plasma intact fibroblast growth factor 23 (iFGF23) ( A ), C-terminal FGF23 (cFGF23) ( B ), and serum parathyroid hormone (PTH) ( C ) with tubular maximum phosphate (P i ) reabsorption (TmP/GFR) and of serum calcitriol ( D ), plasma cFGF23 ( E ), and serum PTH ( F ) with plasma iFGF23. A straight black line was fitted and ROUT method for outlier removal was applied. Black and red dots represent participants on low or high P i diet, respectively. Blue dots represent identified outliers. The dashed line represents 95% confidence interval. The slope was analyzed by the extra sum-of-squares F test. Significance level p < 0.05

    Article Snippet: Tubular maximum P i reabsorption (TmP/GFR) was calculated by using the fractional tubular reabsorption (TRP) of P i with the following equations using spot urine [ ]: \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\begin{array}{l}TRP=1-\left[\left(\frac{{U}_{Pi}}{{P}_{Pi}}\right)*\left(\frac{{P}_{Cr}}{{U}_{Cr}}\right)\right]\\ TRP \le 0.86 \to TmP/GFR=TRP*{P}_{Pi}\\ TRP>0.86 \to TmP/GFR=\left(0.3*\frac{TRP}{1-\left(0.8*TRP\right)}\right)*{P}_{Pi}\end{array}$$\end{document} T R P = 1 - U Pi P Pi ∗ P Cr U Cr T R P ≤ 0.86 → T m P / G F R = T R P ∗ P Pi T R P > 0.86 → T m P / G F R = 0.3 ∗ TRP 1 - 0.8 ∗ T R P ∗ P Pi Daily fractional excretion of P i (FEP i ) was calculated by the following equation using the absolute 24-h urine P i and creatinine: \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$FE{P}_{i}=\frac{{(U}_{Pi}*{P}_{Cr})}{{(P}_{Pi}*{U}_{Cr})}*100$$\end{document} F E P i = ( U Pi ∗ P Cr ) ( P Pi ∗ U Cr ) ∗ 100 Daily renal filtered P i load was calculated with the following equation: \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$Renal\;P_iload/day=\left(\frac{U_{Cr}\ast U_{volume}}{P_{Cr}\ast1440}\right)\ast P_{Pi}$$\end{document} R e n a l P i l o a d / d a y = U Cr * U volume P Cr * 1440 * P Pi Plasma iFGF23, cFGF23, Fetuin-A, and urinary metanephrine were measured with the human iFGF23 and cFGF23 enzyme-linked immunosorbent assay (ELISA) (iFGF23 and cFGF23, Quidel, 60–6600 and 60–6100, respectively), Fetuin-A ELISA (R&D Systems, DFTA00, Lot P413286), and the Metanephrine Urine ELISA (Demeditec Diagnostics GmbH, DEE8400) according to manufacturers’ protocols.

    Techniques: Clinical Proteomics

    Phosphatropic hormones after 5 days of low- or high-phosphate (P i ) diet. Levels of A serum parathyroid hormone (PTH), B plasma intact fibroblast growth factor 23 (iFGF23), C plasma C-terminal FGF23 (cFGF23), D the ratio of iFGF23 (ng/l)/cFGF23 (ng/l) as well as serum E calcidiol, and F calcitriol, and G plasma soluble Klotho, and H Fetuin-A on the final day of both the 5-day low and high P i diet. One reference unit (RU)/ml corresponds to 2 ng/l cFGF23. Blue dots represent differences (Δ) between high P i diet and low P i diet expressed as mean difference ± 95% confidence interval and blue dashed line represents the zero line of the right y-axis. Data was analyzed by the paired t -test ( A – E ) or Wilcoxon test ( F–H ), n = 10, * p < 0.05

    Journal: Pflugers Archiv

    Article Title: Controlled dietary phosphate loading in healthy young men elevates plasma phosphate and FGF23 levels

    doi: 10.1007/s00424-024-03046-4

    Figure Lengend Snippet: Phosphatropic hormones after 5 days of low- or high-phosphate (P i ) diet. Levels of A serum parathyroid hormone (PTH), B plasma intact fibroblast growth factor 23 (iFGF23), C plasma C-terminal FGF23 (cFGF23), D the ratio of iFGF23 (ng/l)/cFGF23 (ng/l) as well as serum E calcidiol, and F calcitriol, and G plasma soluble Klotho, and H Fetuin-A on the final day of both the 5-day low and high P i diet. One reference unit (RU)/ml corresponds to 2 ng/l cFGF23. Blue dots represent differences (Δ) between high P i diet and low P i diet expressed as mean difference ± 95% confidence interval and blue dashed line represents the zero line of the right y-axis. Data was analyzed by the paired t -test ( A – E ) or Wilcoxon test ( F–H ), n = 10, * p < 0.05

    Article Snippet: Tubular maximum P i reabsorption (TmP/GFR) was calculated by using the fractional tubular reabsorption (TRP) of P i with the following equations using spot urine [ ]: \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\begin{array}{l}TRP=1-\left[\left(\frac{{U}_{Pi}}{{P}_{Pi}}\right)*\left(\frac{{P}_{Cr}}{{U}_{Cr}}\right)\right]\\ TRP \le 0.86 \to TmP/GFR=TRP*{P}_{Pi}\\ TRP>0.86 \to TmP/GFR=\left(0.3*\frac{TRP}{1-\left(0.8*TRP\right)}\right)*{P}_{Pi}\end{array}$$\end{document} T R P = 1 - U Pi P Pi ∗ P Cr U Cr T R P ≤ 0.86 → T m P / G F R = T R P ∗ P Pi T R P > 0.86 → T m P / G F R = 0.3 ∗ TRP 1 - 0.8 ∗ T R P ∗ P Pi Daily fractional excretion of P i (FEP i ) was calculated by the following equation using the absolute 24-h urine P i and creatinine: \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$FE{P}_{i}=\frac{{(U}_{Pi}*{P}_{Cr})}{{(P}_{Pi}*{U}_{Cr})}*100$$\end{document} F E P i = ( U Pi ∗ P Cr ) ( P Pi ∗ U Cr ) ∗ 100 Daily renal filtered P i load was calculated with the following equation: \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$Renal\;P_iload/day=\left(\frac{U_{Cr}\ast U_{volume}}{P_{Cr}\ast1440}\right)\ast P_{Pi}$$\end{document} R e n a l P i l o a d / d a y = U Cr * U volume P Cr * 1440 * P Pi Plasma iFGF23, cFGF23, Fetuin-A, and urinary metanephrine were measured with the human iFGF23 and cFGF23 enzyme-linked immunosorbent assay (ELISA) (iFGF23 and cFGF23, Quidel, 60–6600 and 60–6100, respectively), Fetuin-A ELISA (R&D Systems, DFTA00, Lot P413286), and the Metanephrine Urine ELISA (Demeditec Diagnostics GmbH, DEE8400) according to manufacturers’ protocols.

    Techniques:

    Plasma/serum and urine hormones after 5 days of low- or high-phosphate (P i ) diet. Data are presented either as mean ± SD (paired t -test) or median and interquartile range (Wilcoxon test)

    Journal: Pflugers Archiv

    Article Title: Controlled dietary phosphate loading in healthy young men elevates plasma phosphate and FGF23 levels

    doi: 10.1007/s00424-024-03046-4

    Figure Lengend Snippet: Plasma/serum and urine hormones after 5 days of low- or high-phosphate (P i ) diet. Data are presented either as mean ± SD (paired t -test) or median and interquartile range (Wilcoxon test)

    Article Snippet: Tubular maximum P i reabsorption (TmP/GFR) was calculated by using the fractional tubular reabsorption (TRP) of P i with the following equations using spot urine [ ]: \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\begin{array}{l}TRP=1-\left[\left(\frac{{U}_{Pi}}{{P}_{Pi}}\right)*\left(\frac{{P}_{Cr}}{{U}_{Cr}}\right)\right]\\ TRP \le 0.86 \to TmP/GFR=TRP*{P}_{Pi}\\ TRP>0.86 \to TmP/GFR=\left(0.3*\frac{TRP}{1-\left(0.8*TRP\right)}\right)*{P}_{Pi}\end{array}$$\end{document} T R P = 1 - U Pi P Pi ∗ P Cr U Cr T R P ≤ 0.86 → T m P / G F R = T R P ∗ P Pi T R P > 0.86 → T m P / G F R = 0.3 ∗ TRP 1 - 0.8 ∗ T R P ∗ P Pi Daily fractional excretion of P i (FEP i ) was calculated by the following equation using the absolute 24-h urine P i and creatinine: \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$FE{P}_{i}=\frac{{(U}_{Pi}*{P}_{Cr})}{{(P}_{Pi}*{U}_{Cr})}*100$$\end{document} F E P i = ( U Pi ∗ P Cr ) ( P Pi ∗ U Cr ) ∗ 100 Daily renal filtered P i load was calculated with the following equation: \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$Renal\;P_iload/day=\left(\frac{U_{Cr}\ast U_{volume}}{P_{Cr}\ast1440}\right)\ast P_{Pi}$$\end{document} R e n a l P i l o a d / d a y = U Cr * U volume P Cr * 1440 * P Pi Plasma iFGF23, cFGF23, Fetuin-A, and urinary metanephrine were measured with the human iFGF23 and cFGF23 enzyme-linked immunosorbent assay (ELISA) (iFGF23 and cFGF23, Quidel, 60–6600 and 60–6100, respectively), Fetuin-A ELISA (R&D Systems, DFTA00, Lot P413286), and the Metanephrine Urine ELISA (Demeditec Diagnostics GmbH, DEE8400) according to manufacturers’ protocols.

    Techniques:

    Associations between phosphatropic hormones and tubular maximal phosphate reabsorption. Non-linear regression analysis of plasma intact fibroblast growth factor 23 (iFGF23) ( A ), C-terminal FGF23 (cFGF23) ( B ), and serum parathyroid hormone (PTH) ( C ) with tubular maximum phosphate (P i ) reabsorption (TmP/GFR) and of serum calcitriol ( D ), plasma cFGF23 ( E ), and serum PTH ( F ) with plasma iFGF23. A straight black line was fitted and ROUT method for outlier removal was applied. Black and red dots represent participants on low or high P i diet, respectively. Blue dots represent identified outliers. The dashed line represents 95% confidence interval. The slope was analyzed by the extra sum-of-squares F test. Significance level p < 0.05

    Journal: Pflugers Archiv

    Article Title: Controlled dietary phosphate loading in healthy young men elevates plasma phosphate and FGF23 levels

    doi: 10.1007/s00424-024-03046-4

    Figure Lengend Snippet: Associations between phosphatropic hormones and tubular maximal phosphate reabsorption. Non-linear regression analysis of plasma intact fibroblast growth factor 23 (iFGF23) ( A ), C-terminal FGF23 (cFGF23) ( B ), and serum parathyroid hormone (PTH) ( C ) with tubular maximum phosphate (P i ) reabsorption (TmP/GFR) and of serum calcitriol ( D ), plasma cFGF23 ( E ), and serum PTH ( F ) with plasma iFGF23. A straight black line was fitted and ROUT method for outlier removal was applied. Black and red dots represent participants on low or high P i diet, respectively. Blue dots represent identified outliers. The dashed line represents 95% confidence interval. The slope was analyzed by the extra sum-of-squares F test. Significance level p < 0.05

    Article Snippet: Tubular maximum P i reabsorption (TmP/GFR) was calculated by using the fractional tubular reabsorption (TRP) of P i with the following equations using spot urine [ ]: \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\begin{array}{l}TRP=1-\left[\left(\frac{{U}_{Pi}}{{P}_{Pi}}\right)*\left(\frac{{P}_{Cr}}{{U}_{Cr}}\right)\right]\\ TRP \le 0.86 \to TmP/GFR=TRP*{P}_{Pi}\\ TRP>0.86 \to TmP/GFR=\left(0.3*\frac{TRP}{1-\left(0.8*TRP\right)}\right)*{P}_{Pi}\end{array}$$\end{document} T R P = 1 - U Pi P Pi ∗ P Cr U Cr T R P ≤ 0.86 → T m P / G F R = T R P ∗ P Pi T R P > 0.86 → T m P / G F R = 0.3 ∗ TRP 1 - 0.8 ∗ T R P ∗ P Pi Daily fractional excretion of P i (FEP i ) was calculated by the following equation using the absolute 24-h urine P i and creatinine: \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$FE{P}_{i}=\frac{{(U}_{Pi}*{P}_{Cr})}{{(P}_{Pi}*{U}_{Cr})}*100$$\end{document} F E P i = ( U Pi ∗ P Cr ) ( P Pi ∗ U Cr ) ∗ 100 Daily renal filtered P i load was calculated with the following equation: \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$Renal\;P_iload/day=\left(\frac{U_{Cr}\ast U_{volume}}{P_{Cr}\ast1440}\right)\ast P_{Pi}$$\end{document} R e n a l P i l o a d / d a y = U Cr * U volume P Cr * 1440 * P Pi Plasma iFGF23, cFGF23, Fetuin-A, and urinary metanephrine were measured with the human iFGF23 and cFGF23 enzyme-linked immunosorbent assay (ELISA) (iFGF23 and cFGF23, Quidel, 60–6600 and 60–6100, respectively), Fetuin-A ELISA (R&D Systems, DFTA00, Lot P413286), and the Metanephrine Urine ELISA (Demeditec Diagnostics GmbH, DEE8400) according to manufacturers’ protocols.

    Techniques:

    Acute effects of a single PTH injection in WT mice. Baseline cFGF23 levels in different experiments ranged between 218 ± 19 and 345 ± 34 pg/mL, and peak cFGF23 levels ranged between 578 ± 114 and 1244 ± 110 pg/mL; therefore, changes in cFGF23 (and iFGF23) levels are reported as percentage of change from baseline. (a) Plasma phosphate levels 2, 6, and 24 hours after PTH or vehicle injection. (b) Plasma cFGF23 levels, expressed as percentage over preinjection baseline, at 2, 4, 6, and 24 hours after PTH injection. (c) Plasma iFGF23 levels, expressed as percentage over preinjection baseline, at 2, 4, 6, and 24 hours after PTH injection. n = 5 or more mice per group. (d) Ratio of cleaved/total FGF23 was calculated as follows: (value measured by cFGF23 ELISA − value measured by iFGF23 ELISA)/value measured by cFGF23 ELISA. n = 7–8 per group. *P < 0.05.

    Journal: Endocrinology

    Article Title: Acute Parathyroid Hormone Injection Increases C-Terminal but Not Intact Fibroblast Growth Factor 23 Levels

    doi: 10.1210/en.2016-1451

    Figure Lengend Snippet: Acute effects of a single PTH injection in WT mice. Baseline cFGF23 levels in different experiments ranged between 218 ± 19 and 345 ± 34 pg/mL, and peak cFGF23 levels ranged between 578 ± 114 and 1244 ± 110 pg/mL; therefore, changes in cFGF23 (and iFGF23) levels are reported as percentage of change from baseline. (a) Plasma phosphate levels 2, 6, and 24 hours after PTH or vehicle injection. (b) Plasma cFGF23 levels, expressed as percentage over preinjection baseline, at 2, 4, 6, and 24 hours after PTH injection. (c) Plasma iFGF23 levels, expressed as percentage over preinjection baseline, at 2, 4, 6, and 24 hours after PTH injection. n = 5 or more mice per group. (d) Ratio of cleaved/total FGF23 was calculated as follows: (value measured by cFGF23 ELISA − value measured by iFGF23 ELISA)/value measured by cFGF23 ELISA. n = 7–8 per group. *P < 0.05.

    Article Snippet: FGF23 was measured using the rodent-specific cFGF23 and iFGF23 enzyme-linked immunosorbent assay (ELISA) kits (Immutopics, San Clemente, CA).

    Techniques: Injection, Clinical Proteomics, Enzyme-linked Immunosorbent Assay

    Dose-response effects of cFGF23 and iFGF23 after PTH injection. PTH doses of 12.5 and 50 nmol/kg were injected, and (a) peak cFGF23 levels (at 2 hours) and (b) nadir iFGF23 levels (at 6 hours) are shown. Absolute values are shown from an individual experiment. n = 5 or more mice per group. Bars show significant response by analysis of variance.

    Journal: Endocrinology

    Article Title: Acute Parathyroid Hormone Injection Increases C-Terminal but Not Intact Fibroblast Growth Factor 23 Levels

    doi: 10.1210/en.2016-1451

    Figure Lengend Snippet: Dose-response effects of cFGF23 and iFGF23 after PTH injection. PTH doses of 12.5 and 50 nmol/kg were injected, and (a) peak cFGF23 levels (at 2 hours) and (b) nadir iFGF23 levels (at 6 hours) are shown. Absolute values are shown from an individual experiment. n = 5 or more mice per group. Bars show significant response by analysis of variance.

    Article Snippet: FGF23 was measured using the rodent-specific cFGF23 and iFGF23 enzyme-linked immunosorbent assay (ELISA) kits (Immutopics, San Clemente, CA).

    Techniques: Injection

    Effects of PTH injection in ADHR mice or in animals pretreated with the furin inhibitor 537076 (at concentration 7.5 μg/g) or PBS vehicle. (a) cFGF23 and (b) iFGF23 changes after PTH injection (50 nmol/kg), or vehicle (10 mm citric acid, 150 mm NaCl, 0.05% Tween 80, pH 5.0) in ADHR mutant mice. n = 6–8 per group. Baseline cFGF23 levels in ADHR mutant mice in different experiments ranged between 190 ± 13 and 281 ± 19 pg/mL, and peak cFGF23 levels ranged between 485 ± 78 and 1242 ± 239 pg/mL, whereas baseline iFGF23 levels in ADHR mutant mice in different experiments ranged between 262 ± 23 and 345±18 pg/mL, and peak iFGF23 levels ranged between 450 ± 25 and 975 ± 149 pg/mL. Changes in cFGF23 and iFGF23 levels are reported as percentage of change from baseline. (c) cFGF23 and (d) iFGF23 levels in WT mice all injected with PTH; furin refers to mice pretreated with furin inhibitor, and vehicle refers to mice pretreated with vehicle as described. n > 4 mice per group. *P < 0.05. Hashed line shows 100% of baseline.

    Journal: Endocrinology

    Article Title: Acute Parathyroid Hormone Injection Increases C-Terminal but Not Intact Fibroblast Growth Factor 23 Levels

    doi: 10.1210/en.2016-1451

    Figure Lengend Snippet: Effects of PTH injection in ADHR mice or in animals pretreated with the furin inhibitor 537076 (at concentration 7.5 μg/g) or PBS vehicle. (a) cFGF23 and (b) iFGF23 changes after PTH injection (50 nmol/kg), or vehicle (10 mm citric acid, 150 mm NaCl, 0.05% Tween 80, pH 5.0) in ADHR mutant mice. n = 6–8 per group. Baseline cFGF23 levels in ADHR mutant mice in different experiments ranged between 190 ± 13 and 281 ± 19 pg/mL, and peak cFGF23 levels ranged between 485 ± 78 and 1242 ± 239 pg/mL, whereas baseline iFGF23 levels in ADHR mutant mice in different experiments ranged between 262 ± 23 and 345±18 pg/mL, and peak iFGF23 levels ranged between 450 ± 25 and 975 ± 149 pg/mL. Changes in cFGF23 and iFGF23 levels are reported as percentage of change from baseline. (c) cFGF23 and (d) iFGF23 levels in WT mice all injected with PTH; furin refers to mice pretreated with furin inhibitor, and vehicle refers to mice pretreated with vehicle as described. n > 4 mice per group. *P < 0.05. Hashed line shows 100% of baseline.

    Article Snippet: FGF23 was measured using the rodent-specific cFGF23 and iFGF23 enzyme-linked immunosorbent assay (ELISA) kits (Immutopics, San Clemente, CA).

    Techniques: Injection, Concentration Assay, Mutagenesis